Oct 14, 2024 | False Claims Act, Health Care, Health Care Fraud, White Collar Crime
On October 10, 2024, the DOJ announced that Teva Pharmaceuticals had agreed to pay $450 million to resolve two matters, one of which was the result of an investigation conducted pursuant to the False Claims Act (FCA). According to the DOJ, the settlement encompasses...
Jun 27, 2024 | Criminal Matters, federal investigations, SEC Investigations, White Collar Crime
This week, the Supreme Court issued a flurry of important decisions, including two major decisions related to white collar criminal enforcement, both which deal significant blows to the government. Snyder v. United States – Supreme Court Significantly Limits Scope of...
